Nexien Biopharma, Inc. financial data

Symbol
NXEN on OTC
Location
4340 E Kentucky Ave, Suite 206, Glendale, CO
State of incorporation
Delaware
Fiscal year end
June 30
Former names
Intiva BioPharma Inc. (to 9/12/2018), Kinder Holding Corp. (to 11/6/2017)
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 6.49 % -80.8%
Debt-to-equity -107 % +29.3%
Return On Equity 83.3 % -59.5%
Return On Assets -1.2K % -199%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.5M shares +6.22%
Common Stock, Shares, Outstanding 67.5M shares +7.49%
Entity Public Float 1.59M USD -6.51%
Common Stock, Value, Issued 6.75K USD +7.49%
Weighted Average Number of Shares Outstanding, Basic 66.4M shares +5.98%
Weighted Average Number of Shares Outstanding, Diluted 66.4M shares +5.98%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 0 USD
General and Administrative Expense 124K USD -51.1%
Net Income (Loss) Attributable to Parent -246K USD +32.6%
Earnings Per Share, Basic -0.01 USD/shares 0%
Earnings Per Share, Diluted -0.01 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.1K USD -81.4%
Assets, Current 14.3K USD -75.5%
Assets 14.3K USD -75.5%
Liabilities, Current 340K USD +17.7%
Liabilities 340K USD +17.7%
Retained Earnings (Accumulated Deficit) -11.4M USD -2.2%
Stockholders' Equity Attributable to Parent -325K USD -41.2%
Liabilities and Equity 14.3K USD -75.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.1K USD -8.46%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 67.5M shares +7.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.1K USD -8.46%
Deferred Tax Assets, Valuation Allowance 689K USD +5.88%
Deferred Tax Assets, Operating Loss Carryforwards 689K USD +5.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 11.1M USD +1.85%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%